Tr1X

Tr1X

62
Reputation
Mid
5 open positions
Last updated Oct 22, 2026
11-50 employees
Remote0%
Hybrid0%
On-site100%
Salary shown100%
Avg. listing50d
This month2 new · 1 closed

Director, Medical & Regulatory Writing

$200k–$220k/year
48
Low

About Tr1X Tr1X is a clinical-stage biotechnology company developing engineered Tr1 cell therapies to restore immune balance in autoimmune and inflammatory diseases. Leveraging the unique biology of Tr1 cells, the company is advancing a pipeline of off-the-shelf allogeneic and in vivo CAR-Tr1 therap

Legal & ComplianceRegulatoryExecutive
See 2 similar>
4 0 0 10d ago

Director / Senior Director, Program Management

$210k–$230k/year
39
Lowest

About Tr1X Tr1X is a clinical-stage biotechnology company developing engineered Tr1 cell therapies to restore immune balance in autoimmune and inflammatory diseases. Leveraging the unique biology of Tr1 cells, the company is advancing a pipeline of off-the-shelf allogeneic and in vivo CAR-Tr1 therap

OtherProgram ManagementSenior
See 2 similar>
4 0 0 15d ago

Senior Scientist, Immunology - Targeted LNP Delivery

$152k–$165k/year
34
Lowest

About Tr1X Tr1X is a clinical-stage biotechnology company developing engineered Tr1 cell therapies to restore immune balance in autoimmune and inflammatory diseases. Leveraging the unique biology of Tr1 cells, the company is advancing a pipeline of off-the-shelf allogeneic and in vivo CAR-Tr1 therap

OtherScientistSenior
See 2 similar>
8 0 0 1mo ago

Principal Scientist, LNP Platform & Process Development

$169k–$185k/year
34
Lowest

About Tr1X Tr1X is a clinical-stage biotechnology company developing engineered Tr1 cell therapies to restore immune balance in autoimmune and inflammatory diseases. Leveraging the unique biology of Tr1 cells, the company is advancing a pipeline of off-the-shelf allogeneic and in vivo CAR-Tr1 therap

OtherDevelopmentLead
See 2 similar>
4 0 0 1mo ago

Senior Director, Quality

$240k–$270k/year
34
Lowest

About Tr1X Tr1X is a clinical-stage biotechnology company developing engineered Tr1 cell therapies to restore immune balance in autoimmune and inflammatory diseases. Leveraging the unique biology of Tr1 cells, the company is advancing a pipeline of off-the-shelf allogeneic and in vivo CAR-Tr1 therap

OtherDirectorSenior
See 2 similar>
5 0 0 2mo ago